Here you will find all the research and views on DR. REDDYS LAB that we post on Equitymaster. Use the tools to customize the results to suit your preference!
Here's an analysis of the annual report of DR. REDDYS LAB for 2023-24. It includes a full income statement, balance sheet and cash flow analysis of DR. REDDYS LAB. Also includes updates on the valuation of DR. REDDYS LAB.
Check out DR. REDDYS LAB fact sheet and DR. REDDYS LAB financial results online at Equitymaster.
Check out latest DR. REDDYS LAB Quarterly Results online at Equitymaster.
DR. REDDYS LAB: Get the latest DR. REDDYS LAB Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com.
With a bull rally in the dollar sparked by Trump's return to the White House, these five stocks are poised to benefit.
This largecap stock is set to trade ex-split next week. More details inside.
Your dividend stocks watchlist for 2025.
Active pharmaceutical ingredients (APIs) are the key ingredients in medicines. Here are the top Indian leading manufacturers of API.
These 5 companies are fundamentally strong and can ride out any storm.
Find out what's driving the rally in this large-cap stock and whether there's more steam left.
During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.
In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.
With the second wave pushing up sales of medicines, Indian pharma companies are likely to see traction in their volumes.
Indian share markets snapped two weeks of gains as covid second wave and inflation concerns dampened sentiment.
The company's board recommended a final dividend of Rs 25 for financial year 2020-21.